1. Home
  2. MREO vs IMXI Comparison

MREO vs IMXI Comparison

Compare MREO & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • IMXI
  • Stock Information
  • Founded
  • MREO 2015
  • IMXI 1994
  • Country
  • MREO United Kingdom
  • IMXI United States
  • Employees
  • MREO N/A
  • IMXI N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • IMXI Retail: Computer Software & Peripheral Equipment
  • Sector
  • MREO Health Care
  • IMXI Technology
  • Exchange
  • MREO Nasdaq
  • IMXI Nasdaq
  • Market Cap
  • MREO 281.6M
  • IMXI 278.2M
  • IPO Year
  • MREO N/A
  • IMXI N/A
  • Fundamental
  • Price
  • MREO $1.79
  • IMXI $14.44
  • Analyst Decision
  • MREO Strong Buy
  • IMXI Buy
  • Analyst Count
  • MREO 5
  • IMXI 6
  • Target Price
  • MREO $7.40
  • IMXI $19.60
  • AVG Volume (30 Days)
  • MREO 1.2M
  • IMXI 1.3M
  • Earning Date
  • MREO 08-12-2025
  • IMXI 11-07-2025
  • Dividend Yield
  • MREO N/A
  • IMXI N/A
  • EPS Growth
  • MREO N/A
  • IMXI N/A
  • EPS
  • MREO N/A
  • IMXI 1.65
  • Revenue
  • MREO $500,000.00
  • IMXI $642,149,000.00
  • Revenue This Year
  • MREO N/A
  • IMXI N/A
  • Revenue Next Year
  • MREO $55.50
  • IMXI $1.87
  • P/E Ratio
  • MREO N/A
  • IMXI $8.78
  • Revenue Growth
  • MREO N/A
  • IMXI N/A
  • 52 Week Low
  • MREO $1.47
  • IMXI $8.58
  • 52 Week High
  • MREO $4.72
  • IMXI $22.37
  • Technical
  • Relative Strength Index (RSI)
  • MREO 52.86
  • IMXI 70.58
  • Support Level
  • MREO $1.68
  • IMXI $14.40
  • Resistance Level
  • MREO $1.83
  • IMXI $14.70
  • Average True Range (ATR)
  • MREO 0.08
  • IMXI 0.16
  • MACD
  • MREO 0.03
  • IMXI -0.14
  • Stochastic Oscillator
  • MREO 82.61
  • IMXI 27.03

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

Share on Social Networks: